Who Owns Praxis Precision Medicines Stock?
NASDAQ: PRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 127.09%
- Institutions (% of float)
- 127.44%
- Held by insiders
- 0.28%
- Institutional holders
- 471
- Institutions 99.7%
- Insiders 0.3%
- Public and other 0.0%
Who owns Praxis Precision Medicines stock?
Institutional investors own about 127.1% of Praxis Precision Medicines's shares, spread across 471 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.28% of PRAX.
The largest institutional holders are Janus Henderson Group Ltd. (12.34%), FMR, LLC (9.44%) and Blackrock Inc. (7.99%). Together, the top 10 institutions control 64.5% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their PRAX positions and 7 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PRAX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Janus Henderson Group Ltd. | 3.45M | 12.34% | -0.3% |
| FMR, LLC | 2.64M | 9.44% | +13.8% |
| Blackrock Inc. | 2.23M | 7.99% | -2.6% |
| Perceptive Advisors Llc | 2.02M | 7.24% | -0.6% |
| Baker Bros. Advisors, LP | 1.75M | 6.27% | 0.0% |
| Orbis Allan Gray Ltd | 1.36M | 4.87% | -11.1% |
| Vanguard Portfolio Management LLC | 1.30M | 4.67% | -2.3% |
| Vanguard Capital Management LLC | 1.23M | 4.40% | -0.5% |
| State Street Corporation | 1.04M | 3.74% | +1.8% |
| Adage Capital Partners GP L.L.C. | 981.52K | 3.51% | -3.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PRAX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 885.41K | 3.17% |
| iShares Trust-iShares Russell 2000 ETF | 650.75K | 2.33% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 639.58K | 2.29% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 427.95K | 1.53% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 409.43K | 1.46% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 405.02K | 1.45% |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 383.83K | 1.37% |
| JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund | 358.09K | 1.28% |
| Manager Directed Portfolios-Hood River Small-Cap Growth Fund | 308.60K | 1.10% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 300.87K | 1.08% |
Frequently asked questions
Who is the largest shareholder of Praxis Precision Medicines?
Janus Henderson Group Ltd. is the largest institutional shareholder of PRAX, owning 12.34% of shares outstanding (3.45M shares) as of its latest 13F filing.
What percentage of Praxis Precision Medicines is owned by institutions?
Institutions own about 127.1% of PRAX shares and 127.4% of the public float.
How much of Praxis Precision Medicines do insiders own?
Insiders, such as officers and directors, own about 0.28% of PRAX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.